ANDREA MARIE PERONE
GREENBRAE, CA
Browse related groups: CA GENZYME CORPORATION All categories
General Payments — all program years on this page
$805.63
- Category: General Payments
- Program years: PY2021–2024
- Record count: 29
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $271.82 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.82 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $119.56 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.87 | 2 |
| Acerta Pharma LLC | $49.55 | 2 |
| CSL Behring | $20.19 | 1 |
| Octapharma USA, Inc. | $18.65 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087295681 | Novartis Pharmaceuticals Corporation | $34.78 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087295693 | Novartis Pharmaceuticals Corporation | $29.09 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1123307822 | AstraZeneca Pharmaceuticals LP | $34.35 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1123311904 | AstraZeneca Pharmaceuticals LP | $15.20 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1134657465 | CSL Behring | $20.19 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139732640 | GENZYME CORPORATION | $119.56 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142323168 | Octapharma USA, Inc. | $18.65 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.